MITODAC Trademark

Trademark Overview


On Tuesday, October 11, 2022, a trademark application was filed for MITODAC with the United States Patent and Trademark Office. The USPTO has given the MITODAC trademark a serial number of 97627312. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Tuesday, December 3, 2024. This trademark is owned by Curome Biosciences Co., Ltd.. The MITODAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating brain dysfunction; pharmaceutical preparations for treating metabolic disorders; vaccines; pharmaceutical preparations for preventing and treating obesity; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; cardiovascular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical drugs for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical compositions for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceuticals for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparati...
mitodac

General Information


Serial Number97627312
Word MarkMITODAC
Filing DateTuesday, October 11, 2022
Status651 - SUSPENSION INQUIRY - MAILED
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating brain dysfunction; pharmaceutical preparations for treating metabolic disorders; vaccines; pharmaceutical preparations for preventing and treating obesity; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; cardiovascular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical drugs for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical compositions for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceuticals for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations acting on the central nervous system; nutraceutical preparations for therapeutic or medical purposes for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the treatment of degenerative brain disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCurome Biosciences Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChungcheongbuk-do, 28160
KR

Trademark Events


Event DateEvent Description
Friday, October 14, 2022NEW APPLICATION ENTERED
Wednesday, October 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 26, 2023ASSIGNED TO EXAMINER
Wednesday, July 26, 2023SUSPENSION LETTER WRITTEN
Wednesday, July 26, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, July 26, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 26, 2023NON-FINAL ACTION WRITTEN
Wednesday, July 26, 2023NON-FINAL ACTION E-MAILED
Wednesday, July 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, October 26, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, January 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2024SUSPENSION LETTER WRITTEN
Wednesday, January 31, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, January 31, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, November 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, November 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 3, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, November 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, November 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 3, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, December 3, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, December 3, 2024INQUIRY TO SUSPENSION E-MAILED